Read-Gene S.A. (WSE: RDG)
Poland
· Delayed Price · Currency is PLN
4.960
0.00 (0.00%)
Jan 20, 2025, 10:45 AM CET
Read-Gene Revenue
Read-Gene had revenue of 3.34M PLN in the quarter ending September 30, 2024, with 45.40% growth. This brings the company's revenue in the last twelve months to 12.67M, up 48.35% year-over-year. In the year 2023, Read-Gene had annual revenue of 10.15M with 40.14% growth.
Revenue (ttm)
12.67M
Revenue Growth
+48.35%
P/S Ratio
4.28
Revenue / Employee
575.93K
Employees
29
Market Cap
54.23M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 10.15M | 2.91M | 40.14% |
Dec 31, 2022 | 7.24M | 787.35K | 12.20% |
Dec 31, 2021 | 6.45M | 384.57K | 6.34% |
Dec 31, 2020 | 6.07M | -296.62K | -4.66% |
Dec 31, 2019 | 6.37M | -758.81K | -10.65% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
NEUCA | 12.34B |
Synektik Spólka Akcyjna | 624.80M |
Voxel | 492.41M |
Celon Pharma | 209.54M |
Selvita | 334.42M |
Ryvu Therapeutics | 91.18M |
Centrum Medyczne ENEL-MED | 680.32M |
Mercator Medical | 488.78M |